← Leaderboards
Angela K Pannier
University Of Nebraska Lincoln
$2,974,755
Attributed
$3,171,937
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,171,937 · 2
By mechanism
DP2$2,777,572 · 1
R21$394,365 · 1
Top collaborators
- Amanda Ellen Ramer-Tait2 shared
Most similar at University Of Nebraska Lincoln
Same institution · by research overlap
- Amanda Ellen Ramer-Tait$1,568,758
Others in their field
Other Emerging Leaders on “Gene Therapy”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- George Mitra · Leidos Biomedical Research, Inc.$23,876,869
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Gene TherapyTransfectionCellsGenesGene DeliveryProteinsSuccessLaboratoriesDesignPlasmid DnaNanoparticleStem CellsProductionRegenerative MedicineAdultPropertyAwardLibrariesNon-Viral Gene DeliveryCytotoxicityDna DeliveryModificationIn VitroPharmaceutical Preparations
Grant awards (5)
Developing Outer Membranes Vesicles from Commensal Gut Bacteria as an Oral Gene Delivery Platform$178,483
R21 · FY2025 · TR · contact PI
Developing Outer Membranes Vesicles from Commensal Gut Bacteria as an Oral Gene Delivery Platform$215,882
R21 · FY2024 · TR · contact PI
Using Cell Priming and Telecommunications Modeling to Enhance Gene Delivery for Stem Cell Therapies$445,500
DP2 · FY2022 · EB · contact PI
Supplement to NIH DP2: Engineering Human Mesenchymal Stem Cells through Primed Transfection as a Cell Therapy for Alzheimer's Disease$134,572
DP2 · FY2019 · EB · contact PI
Using Cell Priming and Telecommunications Modeling to Enhance Gene Delivery for Stem Cell Therapies$2,197,500
DP2 · FY2017 · EB · contact PI